🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Brittany Bychkovsky, MD and colleagues on your JAMA Oncology publication examining "Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2" #BreastCancer #bcsm

Proud to take part in a successful work at Dana-Farber that will impact the clinical approach to patients with CHEK2 variants. Published in JAMA Oncology. It is a great pleasure to work with Huma Rana, MD, MPH Brittany Bychkovsky, MD judy garber Carrie Horton Ambry Genetics jamanetwork.com/journals/jamao…

Genomic constraint metric is now available on the #gnomAD browser. To learn more about the genomic constraint metric view the preprint on bioRxiv (biorxiv.org/content/10.110…) or attend Siwei Chen’s #ASHG22 platform presentation on 10/28 10:30am in rm 502

Checking CHEK2! Changed the clinical approach to CHEK2! Largest study to-date of ~4K CHEK2 PVs CHEK2 PVs were not associated with colorectal cancer but were associated with breast, kidney and thyroid cancers. Proud to take part as the co-first author in this successful work!

Andrew Binns EACR 🙏🏻🙏🏻🙏🏻

Ambry talked with Dr. Huma Q. Rana about her Journal of Clinical Oncology article. She says, “It is imperative to identify service delivery models to help us meet the increasing demand for timely access to genetic testing.” Check out the full article: hubs.ly/Q023HpLn0

Adalet bir gün herkese lazım olacak! “Bir oyuncuyu öldürdükleri gün veya en sevdiği şeyi yapmasını engelleyerek sakat bıraktıkları gün, ya da bir hakeme saldırdıkları gün beni hatırlayacaksınız.” 𝟬𝟰.𝟬𝟵.𝟮𝟬𝟮𝟮 Josef de Souza Şiddete maruz kalan Halil Umut Meler’e geçmiş

What happens when #hereditarycancer testing identifies two pathogenic variants? We compared cancer risk in >600 individuals with double PVs to those with a single PV in this publication with Dana-Farber. hubs.ly/Q02qphlm0 #genechat #genechatpubs @nbagaglu Brittany Bychkovsky, MD

Our study at the Dana-Farber has been recently published in Genetics in Medicine Open! It is such a pleasure to be a member of the Dana-Farber Cancer Genetics&Prevention family and to work with the Ambry Genetics team! #hereditarycancer Carrie Horton Brittany Bychkovsky, MD Huma Rana, MD, MPH judy garber

Insights of #cancer burden from a large retrospective study: patients with double pathogenic variants in cancer predisposition genes showed greater burden than those with single gene variants bit.ly/3TDQkfr Huma Rana, MD, MPH #GIMO #MultiplePathogenicVariants #BreastCancer

Excited to announce I'll speak at the IBG Izmir Biomedicine and Genome Center seminar! My talk will cover our team's unique insights into #HereditaryCancer🔬 📅 Date: 20.09.2024 | 11:00 📍 Location: IBG Izmir Biomedicine and Genome Center, Aziz Sancar Auditorium RareBoost

Do cancers always have a genetic component? Huma Rana, MD, MPH, clinical director of Cancer Genetics and Prevention at Dana-Farber, explains how 15% of cancers are linked to inherited mutations. dana-farber.org/health-library…

İmzanı attığın Cumhuriyetin ilelebet bekçisiyiz. ∞ Cumhuriyetimizin kurucusu Ulu Önder Gazi Mustafa Kemal Atatürk'ü saygı, minnet ve özlemle anıyoruz.

Collaborative project with Nihat Buğra Ağaoğlu Huma Rana, MD, MPH and Busra.Unl and many others is now out in Cancers. This work characterizes CHEK2 variants detected among individuals who underwent genetic testing in Turkey. See: mdpi.com/2072-6694/16/2…

Dr. Judy Garber (judy garber) shared updated OlympiA Phase 3 trial results in today's #SABCS24 General Session #olaparib #BRCA1 #BRCA2 #BreastCancer

Check out this recent JAMA Network Open on Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes 🔓pubmed.ncbi.nlm.nih.gov/39745704/ Brittany Bychkovsky, MD Nihat Buğra Ağaoğlu judy garber Huma Rana, MD, MPH

It's a great pleasure to be a part of this wonderful team at Dana-Farber

Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes oncodaily.com/url/239549 Dana-Farber’s Breast Oncology Center JAMA Network Open Brittany Bychkovsky, MD Nihat Buğra Ağaoğlu judy garber Huma Rana, MD, MPH #Cancer #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology